Results 121 to 130 of about 4,420 (152)

5'-end uridine-derived base modification for siRNAs potency reinforcement. [PDF]

Cell Biosci
Yao Y, Qi X, Huang R, Guo T, Ren J, Ma J.   +5 more
europepmc   +1 more source

Investigation of the relationship between carotid intima-media thickness and angiopoietin-like factor 3 levels in metabolic dysfunction-associated steatotic liver disease. [PDF]

Sci Rep
Kadioglu Yeniyurt E, Duran EN, Dumur S, Ekinci I, Yalcinkaya I, Ustuner M, Carpan HE, Anataca G, Akarsu M, Topal U, Uzun H, Tabak O.   +11 more
europepmc   +1 more source

ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting. [PDF]

Front Endocrinol (Lausanne)
Weng S, Ding C, Lin J, Chai D.
europepmc   +1 more source

A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia. [PDF]

Proc Natl Acad Sci U S A
Yang Y, Beigneux AP, Lowe TL, Chen YQ, Xie K, Jung H, Tu Y, Yu RG, Scheithauer JL, Mehta S, Wu J, Alvarez L, Davidson WS, Birrane G, Remaley AT, Sviridov D, Ploug M, Zhen EY, Qian Y, Sloan JH, Siegel RW, Konrad RJ, Fong LG, Young SG.   +23 more
europepmc   +1 more source

Efficacy and safety of small interfering RNA (siRNA) therapies for hypertriglyceridemia and mixed dyslipidemia: an updated systematic review and meta-analysis. [PDF]

Front Pharmacol
Gao Y, Bai Y, Mu X, Pang X.
europepmc   +1 more source

Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias. [PDF]

Int J Mol Sci
Kosmas CE, Rallidis LS, Hoursalas I, Papakonstantinou EJ, Kostara CE.   +4 more
europepmc   +1 more source

Current and Emerging Pharmacological Therapies for Hypertriglyceridemia. [PDF]

Int J Mol Sci
Alhomoud IS.
europepmc   +1 more source

Advanced therapy in familial hypercholesterolemia. [PDF]

Can Fam Physician
Gao E, Brunham LR, Goldman RD.
europepmc   +1 more source

Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome. [PDF]

Circ Rep
Tanaka H, Matsuura Y, Yamamoto K, Komaki S, Yamaguchi M, Moribayashi K, Ideguchi T, Nakai M, Tsuruda T, Kaikita K.   +9 more
europepmc   +1 more source